This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Wen-Bin Ke
Introduction
Wen-Bin Ke is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of novel antibodies. His work focuses on advancing medical treatments through innovative solutions.
Latest Patents
Wen-Bin Ke holds a patent for "Anti-CD73 antibodies and use thereof." This invention relates to a novel antibody and its antigen-binding fragment, which specifically binds to human CD73 at designated epitopes. The patent highlights the unique complementarity-determining regions (CDRs) that enhance the antibody's effectiveness in therapeutic applications.
Career Highlights
Wen-Bin Ke is associated with the Development Center for Biotechnology, where he has been instrumental in research and development efforts. His expertise in antibody technology has positioned him as a key figure in the biotechnology sector.
Collaborations
Wen-Bin Ke has collaborated with several professionals in his field, including Chun-Chung Lee and Yu-Hsun Lo. These partnerships have fostered innovation and contributed to the advancement of biotechnology research.
Conclusion
Wen-Bin Ke's contributions to the field of biotechnology, particularly through his patent on Anti-CD73 antibodies, demonstrate his commitment to advancing medical science. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile